RAD51 GENOTYPE AND TRIPLE-NEGATIVE BREAST CANCER (TNBC) RISK IN POLISH WOMEN

被引:22
|
作者
Smolarz, Beata [1 ]
Zadrozny, Marek [2 ]
Duda-Szymanska, Joanna [1 ,3 ]
Makowska, Marianna [4 ]
Samulak, Dariusz [5 ,6 ,7 ]
Michalska, Magdalena M. [5 ]
Mojs, Ewa [8 ]
Brys, Magdalena
Forma, Ewa [9 ]
Romanowicz-Makowska, Hanna [1 ]
机构
[1] Inst Polish Mothers Mem Hosp, Dept Pathol, Mol Genet Lab, PL-93338 Lodz, Poland
[2] Inst Polish Mothers Mem Hosp, Dept Oncol, PL-93338 Lodz, Poland
[3] Med Univ Lodz, Dept Pathol, Lodz, Poland
[4] Reg Hosp, Lodz, Poland
[5] Reg Hosp, Dept Obstet & Gynaecol, Kalisz, Poland
[6] Poznan Univ Med Sci, Cathedral Mothers & Childs Hlth, Poznan, Poland
[7] Poznan Univ Med Sci, Clin Gynaecol Surg, Poznan, Poland
[8] Poznan Univ Med Sci, Dept Clin Psychol, Poznan, Poland
[9] Univ Lodz, Dept Cytobiochem, PL-90131 Lodz, Poland
关键词
triple-negative breast cancer; RAD51; gene; single nucleotide polymorphism; SINGLE NUCLEOTIDE POLYMORPHISMS; RECOMBINATION REPAIR GENES; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; ASSOCIATION; SUSCEPTIBILITY; XRCC3;
D O I
10.5114/PJP.2013.34602
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The most lethal damage for the cell among all damage is double-strand breaks (DSB) of DNA. DSB cause development of cancer diseases including the triple-negative molecular subtype of breast cancer. The aim of this work was to evaluate the single nucleotide polymorphism -135G>C (rs1801320) of the RAD51 gene encoding DNA repair proteins by homologous recombination (HR) in triple-negative breast cancer (TNBC). We assessed the RAD51 -135G>C polymorphism in 50 women with triple-negative breast cancer and in 50 women from the control group. RAD51 polymorphism was analysed by the PCR-RFLP (restriction fragment length polymorphism) technique. Our results demonstrated a significant positive association between the RAD51 C/C genotype and TNBC, with an adjusted odds ratio (OR) of 5.95 (p = 0.002). The homozygous C/C genotype was found in 68% of breast cancer cases and 20% of controls. The variant 135C allele of RADS/increased TNBC risk. This is the first study linking single nucleotide polymorphisms of the RAD51 gene with TNBC incidence in the population of Polish women. In conclusion, RAD51 polymorphisms may be regarded as predictive factors of triple-negative breast cancer in the female population. Large studies are needed to confirm our findings.
引用
下载
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [21] Phosphoproteomic portraits of triple-negative breast cancer (TNBC)
    Quintela-Fandino, Miguel
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez, Gonzalo
    Pisano, David G.
    Munoz, Javier
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [23] Triple-negative breast cancer in association with RAD51C pathogenic variants
    Blatnik, Ana
    Strojnik, Ksenija
    Banjac, Marta
    Stegel, Vida
    Dragos, Vita Setrajcic
    Skerl, Petra
    Klancar, Gasper
    Novakovic, Srdjan
    Krajc, Mateja
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 551 - 551
  • [24] 'Flying without a Net': Women's Experience with Triple-negative Breast Cancer (TNBC)
    Turkman, Yasemin
    Knobf, Tish
    Kennedy, Holly
    Harris, Lyndsay
    PSYCHO-ONCOLOGY, 2015, 24 : 265 - 265
  • [25] Patterns of Failure in Triple-Negative Breast Cancer (TNBC): A Retrospective Analysis in 476 Women
    Prasad, S.
    Zagar, T. M.
    James, S.
    Walker, P.
    Raab, R.
    Efird, J.
    Biswas, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S98 - S99
  • [26] Detection of homologous recombination repair deficiency (HRD) in treatment-naive early triple-negative breast cancer (TNBC) by RAD51 foci and comparison with DNA-based tests
    Serra Elizalde, V.
    Llop-Guevara, A.
    Pearson, A.
    Cruz, C.
    Castroviejo-Bermejo, M.
    Chopra, N.
    Tovey, H.
    Toms, C.
    Kriplani, D.
    Gevensleben, H.
    Roylance, R.
    Chan, S.
    Tutt, A.
    Skene, A.
    Evans, A.
    Davies, H. R.
    Bliss, J.
    Nik-Zainal, S.
    Balmana, J.
    Turner, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S21 - S22
  • [27] Subtyping of triple-negative breast cancer (TNBC): A cohort study
    Thomssen, Christoph
    Hartung, Caroline
    Porsch, Martin
    Stuckrath, Kathrin
    Buchmann, Jorg
    Kantelhardt, Eva J.
    Vetter, Martina
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Involvement of proinflammatory chemokines in triple-negative breast cancer (TNBC)
    Ignacio, Rosa Mistica C.
    Gibbs, Carla
    Lee, Eun-Sook
    Son, Deok-Soo
    CANCER RESEARCH, 2016, 76
  • [29] Updates on Targeted Therapy for Triple-Negative Breast Cancer (TNBC)
    Noor Z.S.
    Master A.
    Current Breast Cancer Reports, 2018, 10 (4) : 282 - 288
  • [30] A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and ovarian cancer risk in Polish women
    Romanowicz-Makowska, H.
    Smolarz, B.
    Samulak, D.
    Michalska, M.
    Lewy, J.
    Burzynski, M.
    Kokolaszwili, G.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (04) : 406 - 410